On-Site Genetic Testing for Prostate Cancer Increases Patient Compliance
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3 to 98.7 percent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.